Watson's World
By Jesse Reynolds
| 10. 24. 2007
Nobel Prize season has come to an awkward end. Once a day during last week, we heard announcements of the winners in the six fields, including a high-profile award to Al Gore. The recipients will forever be honored to include the word "laureate" in their biographies.
But a few days later, the most prominent Nobel scientist winning scientist deeply marred his reputation. James Watson, who in 1962 won the prize for his elucidation of DNA's structure, unequivocally stated in an interview with the United Kingdom's Sunday Times that black people are less intelligent than whites. Speaking on development programs in Africa, Watson lamented that "all our social policies are based on the fact that their intelligence is the same as ours - whereas all the testing says not really… [P]eople who have to deal with black employees find [equality] is not true."
It may be tempting to dismiss this stunning utterance as the sloppy, irrelevant ramblings of a once-great scientist who is well past his prime. But Watson is a remarkably influential figure who has consistently reduced behavior to biology...
Related Articles
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...